Stacy S, Sheth S, Coleman B, Cerenzia W.  2021.  An assessment of the continuing medical education needs of US physicians in the management of patients with beta thalassemia.. Ann Hematol. 100(1):27-35.

Goel R, Patel EU, Cushing MM, Frank SM, Ness PM, Takemoto CM, Vasovic LV, Sheth S, Nellis ME, Shaz B et al..  2018.  Association of Perioperative Red Blood Cell Transfusions With Venous Thromboembolism in a North American Registry.. JAMA Surg. 153(9):826-833.

Nellis ME, Levasseur J, Stribling J, E Faustino VS, Zantek ND, Sheth S, Karam O.  2019.  Bleeding Scales Applicable to Critically Ill Children: A Systematic Review.. Pediatr Crit Care Med. 20(7):603-607.

Fassel H, Sheth S.  2020.  Bone Marrow Failure in Children: Approach to Diagnosis and Treatment.. Indian J Pediatr. 87(2):141-149.

Al-Samkari H, van Beers EJ, D Morton H, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kuo KHM, Kollmar N et al..  2020.  Characterization of the severe phenotype of pyruvate kinase deficiency.. Am J Hematol.

Weiss M, Jun MParisi, Sheth S.  2019.  Clinical and economic burden of regularly transfused adult patients with β-thalassemia in the United States: A retrospective cohort study using payer claims.. Am J Hematol. 94(5):E129-E132.

Grace RF, Bianchi P, van Beers EJ, Eber SW, Glader B, Yaish HM, Despotovic JM, Rothman JA, Sharma M, McNaull MM et al..  2018.  Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.. Blood. 131(20):2183-2192.

Boscoe AN, Yan Y, Hedgeman E, van Beers EJ, Al-Samkari H, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S et al..  2021.  Comorbidities and complications in adults with pyruvate kinase deficiency.. Eur J Haematol. 106(4):484-492.

Frangoul H, Altshuler D, M Cappellini D, Chen Y-S, Domm J, Eustace BK, Foell J, de la Fuente J, Grupp S, Handgretinger R et al..  2021.  CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.. N Engl J Med. 384(3):252-260.

Hoshino A, Kim HSang, Bojmar L, Gyan KEnnu, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S et al..  2020.  Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.. Cell. 182(4):1044-1061.e18.

Al-Samkari H, van Beers EJ, D Morton H, Eber SW, Chonat S, Kuo KHM, Kollmar N, Wang H, Breakey VR, Sheth S et al..  2022.  Health-related quality of life and fatigue in children and adults with pyruvate kinase deficiency.. Blood Adv. 6(6):1844-1853.

Sheth S.  2014.  Iron Chelation: An Update. Curr Opin Hematol. 21(3):179-85.

Sammet CL, Swaminathan SV, Tang H, Sheth S, Jensen JH, Nunez A, Hultman K, Kim D, Wu EX, Brittenham GM et al..  2013.  Measurement and Correction of Stimulated Echo Contamination in T2-Based Iron Quantification. Magn Reson Imaging. 31(5):664-8.

Sheth S, Allen CJ, Farrell DE, Tripp JH, Jafari R, Wang Y, Brittenham GM.  2019.  Measurement of the liver iron concentration in transfusional iron overload by MRI R2* and by high-transition-temperature superconducting magnetic susceptometry.. Clin Imaging. 55:65-70.

Tang H, Jensen JH, Sammet CL, Sheth S, Swaminathan SV, Hultman K, Kim D, Wu EX, Brown TR, Brittenham GM.  2014.  MR Characterization of Hepatic Storage Iron in Transfusional Iron Overload. J Magn Reson Imaging. 39(2):307-16.

Mensah C, Sheth S.  2021.  Optimal strategies for carrier screening and prenatal diagnosis of α- and β-thalassemia.. Hematology Am Soc Hematol Educ Program. 2021(1):607-613.

Chien KA, Hammad HT, Gerber L, Sheth S, Sockolow R, Kucine N.  2018.  Pediatric Gastroenterologists' Approach to Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease.. J Pediatr Gastroenterol Nutr. 66(2):286-288.

van Beers EJ, van Straaten S, D Morton H, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kwiatkowski JL, Rothman JA et al..  2019.  Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study.. Haematologica. 104(2):e51-e53.

Rapido F, Brittenham GM, Bandyopadhyay S, La Carpia F, L'Acqua C, McMahon DJ, Rebbaa A, Wojczyk BS, Netterwald J, Wang H et al..  2017.  Prolonged Red Cell Storage Before Transfusion Increases Extravascular Hemolysis. J Clin Invest. 127(1):375-382.

Chonat S, Eber SW, Holzhauer S, Kollmar N, D Morton H, Glader B, Neufeld EJ, Yaish HM, Rothman JA, Sharma M et al..  2021.  Pyruvate kinase deficiency in children.. Pediatr Blood Cancer. 68(9):e29148.

Jafari R, Sheth S, Spincemaille P, Nguyen TD, Prince MR, Wen Y, Guo Y, Deh K, Liu Z, Margolis D et al..  2019.  Rapid automated liver quantitative susceptibility mapping.. J Magn Reson Imaging. 50(3):725-732.

L'Acqua C, Bandyopadhyay S, Francis RO, McMahon DJ, Nellis M, Sheth S, Kernie SG, Brittenham GM, Spitalnik SL, Hod EA.  2015.  Red Blood Cell Transfusion is Associated with Increased Hemolysis and an Acute Phase Response in a Subset of Critically Ill Children. Am J Hematol. 90(10):915-20.

Goss C, Giardina P, Degtyaryova D, Kleinert D, Sheth S, Cushing M.  2014.  Red Blood Cell Transfusions for Thalassemia: Results of a Survey Assessing Current Practice and Proposal of Evidence-Based Guidelines. Transfusion. 54(7):1773-81.

Badawy SM, Kattamis A, Ezzat H, Deschamps B, Sicard E, Fradette C, Zhao F, Tricta F, Tsang YChung, Sheth S et al..  2022.  The safety and acceptability of twice-daily deferiprone for transfusional iron overload: A multicentre, open-label, phase 2 study.. Br J Haematol. 197(1):e12-e15.

Grace RF, Rose C, D Layton M, Galactéros F, Barcellini W, D Morton H, van Beers EJ, Yaish H, Ravindranath Y, Kuo KHM et al..  2019.  Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.. N Engl J Med. 381(10):933-944.